Steve Sloan: "Cutting edge technology and science are not sufficient in these situations – we need to develop channels and products that are sustainable by the livestock farmers who are going to use them."
The Global Alliance for Livestock Veterinary Medicine (GALVmed) has secured $28m in funding from the UK’s Department for International Development (DFID) and the Bill & Melinda Gates Foundation to develop livestock vaccines that help protect animals and their human owners living in the world’s poorest areas. Animal Pharm met Director Steve Sloan to find out how he intends to achieve this. 
Photo: GALVmed
GALVmed is a not-for–profit organization with a global mission. Although it is based in Edinburgh, it is about to open an office in Nairobi, Kenya and is planning to open a second in New Delhi, India during 2009, says Mr Sloan.
It was first mooted in 2000, through a meeting between potential donors, academics, government institutions and pharmaceutical companies with a goal of addressing the gap in the availability of vaccines, animal health products and diagnostics for farmers in the developing world through public-private partnership.
It is widely accepted that successful livestock production is essential to lifting local economies out of poverty through providing food and allowing trade for cash or barter, advises Mr Sloan.
However, animal disease is a major constraint....
› Not a subscriber? Subscribe
› Sign up for free trial
› Blog: Down on the Pharm
Email a friend
Digital RSS Feed
